Skip to content

H.R. 171 · 118th Congress (2023–2025)

HALT Fentanyl Act

This bill places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

Additionally, the bill establishes a new, alternative registration process for schedule I research that is funded by the Department of Health and Human Services or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the Food and Drug Administration.

The bill also makes several other changes to registration requirements for conducting research with controlled substances, including

  • permitting a single registration for related research sites in certain circumstances,
  • waiving the requirement for a new inspection in certain situations, and
  • allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.
Show official title

To amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to Health

This bill’s path

This is H.R. 171’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. H. Morgan Griffith (R-VA-9)
Cosponsors
2 cosponsors

1 original · 1 later

  1. Rep. Robert E. Latta (R-OH-5)· Original · Jan 9, 2023
  2. Rep. Brad Finstad (R-MN-1)· Later · Feb 1, 2023
Policy area
Crime and Law Enforcement
Subjects
  • Administrative law and regulatory procedures
  • Department of Justice
  • Drug trafficking and controlled substances
  • Licensing and registrations
  • Research administration and funding

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest
    ▸ 2 committee actions · Jan 9, 2023 – Jan 20, 2023
    1. Referred to committee

      Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

      Sources
    2. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
  3. Expired

    Introduced → Referred to House Health → No further action before the 118th Congress ended.

Committees

  1. HouseEnergy and CommerceReferred Jan 9, 2023
  2. HouseHealthReferred Jan 20, 2023
  3. HouseJudiciaryReferred Jan 9, 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (3)
  1. HALT Fentanyl Act

    Display title, Short title · Introduced in House

  2. Halt All Lethal Trafficking of Fentanyl Act

    Short title · Introduced in House

  3. To amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes.

    Official title · Introduced in House